期刊文献+

基质金属蛋白酶-9与短暂性脑缺血发作近期预后的相关性 被引量:1

Association between matrix metalloproteinase-9 and short-term prognosis of transient ischemic attack
下载PDF
导出
摘要 目的检测短暂性脑缺血发作(TIA)患者发病早期血清基质金属蛋白酶-9(MMP-9)的水平,探讨血清MMP-9水平与TIA近期预后的相关性。方法纳入2012年12月~2013年12月我院神经内科收治的TIA患者110例,分为3组,即TIA缓解组(A组)、反复发作但无脑梗死事件组(B组)、TIA起病后发展为脑梗死组(C组)。所有病例均在起病24 h内采用双抗体夹心酶联免疫吸附法测定血清MMP-9含量。结果三组患者血清MMP-9含量均明显高于对照组(P〈0.01),MMP-9水平由高至低依次为C组、B组和A组。C组与A组比较MMP-9水平比较差异有统计学意义(P〈0.01),B组与A组比较、C组与B组比较,差异无统计学意义(P〉0.05)。在置信度为0.01时,血清MMP-9含量与TIA近期预后存在相关性(P〈0.01)。结论早期血清MMP-9含量增高可能是TIA患者近期预后不佳,尤其是近期发生脑梗死的预测因素。 Objective To investigate the levels of matrix metalloproteinase-9(MMP-9) in TIA patients’ serum, and analyzed the association between MMP-9 and the recent prognosis of TIA. Methods The 110 cases of patients with TIA were admitted to our hospital from December 2012 to December 2013. They were divided into group A(remission group), group B(recurrent people without cerebral infarction) and group C(cerebral infarction). The levels of MMP-9 were detected by ELISA at 24 hours of onset. Results The levels of MMP-9 among the three groups were significantly higher than that in control group(P〈0.01). The level from high to low was group C, group B, group A. There was statistical difference of levels of MMP-9 between group A and group C(P〈0.01). However, there was no statistical significance neither between group A and group B, not between group B and group C(P〉0.05). When the confidence level of0.01, correlation analysis showed that MMP-9 was associated with the short-term prognosis of TIA(P〈0.01). Conclusion Elevated levels of MMP-9 are associated with short-term prognosis of TIA, which may predict the poor outcome of TIA.
作者 李贯绯 李丽
出处 《中国现代医生》 2015年第18期1-3,共3页 China Modern Doctor
关键词 短暂性脑缺血发作 脑梗死 基质金属蛋白酶-9 预后 Transient ischemic attack Cerebral infarction Matrix metalloproteinase-9 Prognosis
  • 相关文献

参考文献3

二级参考文献16

  • 1潘春联,毛善平,董飞,张俊斌.血清基质金属蛋白酶-9、白细胞计数与脑梗死体积及近期预后的关系[J].卒中与神经疾病,2004,11(5):268-270. 被引量:12
  • 2徐群,张毅,苏敏,沈沸,苗玲.缺血再灌注大鼠脑内基质金属蛋白酶的动态变化[J].上海第二医科大学学报,2004,24(10):814-817. 被引量:8
  • 3脑血管疾病分类(1995)(中、英文)[J].中华神经科杂志,1996,29(6):376-378. 被引量:430
  • 4Dzwonek J, Rylski M, Kaczmarek L. Matrix metedloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain [ J]. FEBS Lett,2004,67 ( 1 ) : 129-133.
  • 5Casche Y, Fujimura M, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice:a possible role in blood-brain barrier dysfunction [ J ]. J Cereb Blood Flow Meta, 1999,19 (9) : 1020-1028.
  • 6Aashi M, Wang XY, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the pmteolysis of blood-Brain Barrir and white matter comportrnts after cerebral Ischemia [ J ]. J Neurosci, 2001,21 (19) :7724-7729.
  • 7Mun-Bryce S, Rosenberg GA. Celatinase B modulates selective opening of the blood-brain barrier during inflammation[ J]. Am J Physiol, 2002,274(5 pt 2) : 1203-1208.
  • 8Jiang X, Namum S, Nagata L. Matrix metallopreteinase inhibitor KB- 7785 attenuate brain damage resulting from permunent focal cerebral ischemia in mice[ J]. Neurosci Lett,2001,305 ( 1 ) :41-44.
  • 9Shunichi F, Catherine AF, Takuma M, et al. Focal cerebral ischemia induces active proteases that degrade microvascular matrix [ J ]. Stroke,2004,35 (5) :998-1004.
  • 10Rosenberg MD, Estrada BS, Dencoff BS, et al. Matrix Metalloproteinases and TIMPs Are Associated With Blood Brain Barrier Opening After Reperfusion in Rat Brain [ J]. Stroke, 2002,33 ( 9 ) : 2189- 2197.

共引文献33067

同被引文献9

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部